Dr. Reddy's Launches First Generic Suboxone Film; Indivior May Seek Injunction

Launch comes immediately after FDA approval of Dr. Reddy's and Mylan ANDAs while Indivior appeals district court ruling of non-infringement; Mylan settlement may delay its entry.

Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.

Indivior PLC is looking to ward off the impact of FDA's approval of generic versions of its Suboxone sublingual film (buprenorphine/naltrexone).

The company said it is considering seeking an injunction to stop Dr. Reddy's Laboratories Ltd. "at-risk" launch of the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip